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Background
Down syndrome (DS) patients unanimously develop
pathologies of Alzheimer’s disease (AD) in their 30s or
40s. Since DS is caused by the existence of an extra copy
of chromosome 21 in cells, an over-dosage of genes on
chromosome 21 may play a role in the pathogenesis of DS
and perhaps AD as well. This idea has been well-supported
in the case of the APP gene over-dosage which leads to
overproduction of the neurotoxic b-amyloid (Ab) peptides,
the prime culprit in AD pathogenesis. However, the invol-
vement of other genes on chromosome 21 in AD has
barely been studied. Sorting nexin 27 (SNX27), a brain-
enriched PDZ domain protein, regulates endocytic sorting
and trafficking.
Methods and results
Recently, we showed [1] that Snx27-/- mice have severe
neuronal pathology in the hippocampus and cortex.
Although Snx27+/- mice have grossly normal neuroanat-
omy, we found defects in synaptic function, learning and
memory and a reduction in the amounts of ionotropic
glutamate receptors (NMDA and AMPA receptors) in
these mice. SNX27 interacts with these receptors through
its PDZ domain, regulating their recycling to the plasma
membrane. We demonstrated a concomitant reduced
expression of SNX27 and CCAAT/enhancer binding
protein b (C/EBPb) in Down’s syndrome brains and
identify C/EBPb as a transcription factor for SNX27.
Down’s syndrome causes overexpression of miR-155,
a chromosome 21-encoded microRNA that negatively
regulates C/EBPb, thereby reducing SNX27 expression
and resulting in synaptic dysfunction. Upregulating SNX27
in the hippocampus of Down’s syndrome mice rescues
synaptic and cognitive deficits. In addition to its role in
DS, we also found that over-expression of SNX27 dissoci-
ates PS1/g-secretase complex and reduces the level/ activ-
ity of g-secretase and the production of Ab, whereas and
depletion of SNX27 results in increased g-secretase activity
and Ab production.
Conclusion
Our identification of the role of SNX27 in synaptic
function and in regulating g-secretase activity and Ab
generation establishes a new molecular mechanism for
pathogenesis of both DS and AD.
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